Therapeutic antibodies
Develops therapeutic antibodies under innovative formats to treat incurable cancer.
Source: LinkedIn company description · Retrieved October 13, 2026
SunRock is a biopharmaceutical company developing therapeutic antibodies to treat incurable cancer.
SunRock aims to develop programs from early discovery through completion of phase I clinical trials. SunRock has developed bispecific molecules targeting CCR9 and HER3.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Develops therapeutic antibodies under innovative formats to treat incurable cancer.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 15, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 2, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 21, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.